TOKYO - Japan's health ministry has approved the use of the steroid drug dexamethasone for the treatment of novel coronavirus patients, following the approval of remdesivir in May, it came to light on Tuesday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.